1,088
Views
9
CrossRef citations to date
0
Altmetric
Research Paper

Factors associated with the willingness and acceptance of SARS-CoV-2 vaccine from adult subjects in China

, , , , , & show all
Pages 2405-2414 | Received 12 Dec 2020, Accepted 01 Mar 2021, Published online: 24 Mar 2021

Figures & data

Table 1. The differences in the willingness and acceptance of SARS-CoV-2 vaccine inoculation stratified by sociodemographic and health related characteristics

Table 2. Respondents’ general knowledge and perceptions of SARS-CoV-2 vaccine

Figure 1. Reasons and sources of knowledge about SARS-CoV-2 vaccine inoculation. The reasons why the participants were willing (a) or unwilling (b) to receive the SARS-CoV-2 vaccine and the corresponding numbers, as well as the numbers of participants who obtained vaccine knowledge from different sources (c)

Figure 1. Reasons and sources of knowledge about SARS-CoV-2 vaccine inoculation. The reasons why the participants were willing (a) or unwilling (b) to receive the SARS-CoV-2 vaccine and the corresponding numbers, as well as the numbers of participants who obtained vaccine knowledge from different sources (c)

Table 3. Binary logistic regression analysis for factors associated with the willingness and acceptance of SARS-CoV-2 vaccine inoculation

Table 4. The sources of knowledge about vaccine analyzed via sociodemographic characteristics

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.